KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMY) Assets Average (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Assets Average for 15 consecutive years, with $92.5 billion as the latest value for Q1 2025.

  • On a quarterly basis, Assets Average changed N/A to $92.5 billion in Q1 2025 year-over-year; TTM through Mar 2025 was $92.5 billion, a N/A change, with the full-year FY2025 number at $91.3 billion, changed N/A from a year prior.
  • Assets Average was $92.5 billion for Q1 2025 at Bristol Myers Squibb, down from $93.1 billion in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $115.5 billion in Q1 2021 to a low of $92.5 billion in Q1 2025.
  • A 4-year average of $102.0 billion and a median of $100.5 billion in 2022 define the central range for Assets Average.
  • Biggest YoY gain for Assets Average was 8.04% in 2022; the steepest drop was 11.44% in 2022.
  • Bristol Myers Squibb's Assets Average stood at $110.1 billion in 2021, then dropped by 11.44% to $97.5 billion in 2022, then dropped by 4.48% to $93.1 billion in 2024, then fell by 0.67% to $92.5 billion in 2025.
  • Per Business Quant, the three most recent readings for BMY's Assets Average are $92.5 billion (Q1 2025), $93.1 billion (Q4 2024), and $97.5 billion (Q4 2022).